Early gastric neoplasm
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients diagnosed with upper gastrointestinal tumors and scheduled to undergo upper gastrointestinal endoscopy and/or treatment under sedation Male or female patients aged 18 years or older Patients who have provided written informed consent
Exclusion criteria
Exclusion criteria: Patients with heart failure or unstable hemodynamics in whom sedation during the procedure is considered unsafe Patients for whom endoscopy is generally contraindicated (e.g., those with ileus, gastrointestinal perforation, severe respiratory disease, or severe cardiovascular disease) Patients deemed unsuitable for participation in this study due to serious comorbidities or other medical reasons
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| This study aims to assess whether LCI significantly reduces the number of false-positive detections while maintaining a tumor detection rate of over 95%. | — |
Countries
Japan
Contacts
Kyushu University Hospital Department of Medicine and Bioregulatory Science